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DifferentiationExpression of the HPV E2 open reading frame in cervical cancer cells has been shown to affect the expression
of both viral and cellular genes. We have examined the phenotypic effects of the expression of human
papillomavirus 16 E2 open reading frame in the human keratinocyte cell line HaCaT. Increased levels of
apoptotic cell death were seen within 24 h of the transfection of HPV-16 E2 expression constructs. However,
in those cells which survived selection and retained the intact E2 ORF, long-term stable expression of E2, as
detected by RT-PCR, produced cells which developed phenotypes typical of terminally differentiated cells.
These included characteristic morphological changes and expression of involucrin, ﬁlaggrin and senescence
markers. This provides the ﬁrst evidence of a role for E2 in stimulation of the normal epithelial differentiation
programme, which would promote the progression of the HPV life cycle.njm9@york.ac.uk
, Leeds Institute of Molecular
, Leeds, LS9 7TF, UK.
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Infection of human mucosal or squamous epithelium with papillo-
maviruses results inwart-like lesions (zurHausen andDeVilliers, 1994)
in which the papillomavirus (HPV) life cycle is intimately linked to the
differentiation state of the host epithelial cells. The virus enters the
epithelium throughmicroscopic lesions and infects basal keratinocytes,
where the viral genome is uncoated and early functions are expressed.
The “early” gene products interact with cellular factors to transcribe,
maintain and replicate the viral genome in the proliferating basal layer.
As the host cell differentiates, the viral genome is ampliﬁed, encapsi-
dated by viral structural proteins until mature virus particles are shed
with squames from the epithelial surface.
The E2 proteins (reviewed in Burns et al., 2003) encoded by
papillomaviruses have been shown to play an essential role in the
control of viral replication and transcription. The E2 open reading
frames (ORFs) encode nuclear proteins that bind in a sequence-speciﬁc
manner to the consensus sequence ACCGN4CGGT, which occurs several
times in the virus genome (Androphy et al., 1987; Dostatni et al., 1988).
The E2 protein is a dimer with a tripartite structure, comprising an
N-terminal transactivation module (TAD) of about 200 amino acids,
which includes the transcriptional activation and replication func-tions, a C-terminal module (CT) of about 90 amino acids containing
DNA-binding and protein dimerization domains, and a ﬂexible linker
region of about 80 amino acids which separates the N- and C-terminal
modules (Giri and Yaniv, 1988; Gauthier et al., 1991). The amino acid
sequences of N- and C-terminal modules are highly conserved between
the E2 proteins of different papillomaviruses; whereas the linker region
is more variable, both in sequence and length.
Throughout the vegetative replication cycle, the HPV genome is
maintained as an episome, and an intact E2 ORF is required for episomal
maintenance and high efﬁciency viral DNA replication (Ustav and
Stenlund, 1996; Piirsoo et al., 1996). However, integration into host cell
DNA may occur, particularly with “high risk” HPV types such as 16 and
18 (Durst et al., 1985). Integration generally disrupts the E1/E2 ORFs
(Durst et al., 1985; Daniel et al., 1995) leading to dysregulated
expression of the viral oncoproteins E6 and E7 and progression to
malignancy. Immunostaining of cervical lesions reveals that HPV-16 E2
is expressed in CIN I, CIN II and koilocytes (believed to be sites of viral
replication) but expression is lost in later stages of tumour development
(Maitland et al., 1998), consistent with a role for E2 in repressing HPV
gene expression through the p97 promoter.
Studies examining the role of E2 in mammalian cells have generally
used transiently transfected cancer cell lines (reviewed in Burns et al.
(2003)), where ectopic expression of E2 in cervical carcinoma cell lines
resulted in growth suppression of lines containing HPV DNA, probably
due to repression of endogenous E6/E7 expression (Hwang et al., 1993;
Dowhanick et al., 1995; Goodwin et al., 1998; Naeger et al., 1999; Moon
et al., 2001). Studies in HeLa cells (which contain integrated copies of
HPV-18) indicated that transient overexpression of E2 induces
apoptosis (Desaintes et al., 1997, 1999), which was conﬁrmed for
other cell lines, both HPV-positive and -negative (Webster et al., 2000),
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through activation of caspase 8 (Demeret et al., 2003; Thierry and
Demeret, 2008).
Subsequent studies indicated that prolonged growth arrest due to
sustained expression of E2 in HeLa cells induces senescence, which has
been attributed to loss of E7 expression and re-activation of the Rb
pathway (Goodwin et al., 2000; Wells et al., 2000; Kang et al., 2004;Fig. 1. Cell death 24 h after transfection with various pZeoSV constructs. (A) HaCaT, HeLa (po
constructs as described in Materials and methods and unﬁxed cultures examined after 24 h
optics. Both EGFP-E2 and EGFP-E2 CT were exclusively expressed in the nuclei of trans
concentrated in a perinuclear ring. Arrows show dead and dying green cells. All images w
(B) pZeoSV-E2 transfected HaCaT cells were stained 24 h after transfection by addition of pro
by phase contrast and ﬂuorescent microscopy. PI-positive staining was mostly in ﬂoatin
transactivation as measured by EGFP expression 45 h after co-transfection with pZeoSV con
was used as a positive control. Bars show mean and standard deviation of three experimenJohung et al., 2007). However, since HeLa cells are incapable of terminal
differentiation, it is possible that irreversible senescence may be a
default pathway for cells which exit the cell cycle. The object of the
present study was to stably transfect a p53-negative, HPV-negative,
differentiation-competent, keratinocyte cell line (HaCaT) with HPV-16
E2 and examine the effects of E2 expression on cell growth and
morphology.sitive control) and LNCaP (negative control) cells were transfected with EGFP-E2 fusion
by inverted microscopy. Images show same cells under ﬂuorescence and phase contrast
fected cells (visible in phase contrast images). EGFP-E2 in HaCaT and HeLa became
ere captured using the same magniﬁcation and exposure settings. Scale bar=40 μm.
pidium iodide (PI) directly into the medium and unﬁxed cultures viewed within 15 min
g cells (not visible) or detaching, dying cells. Scale bar=200 μm. (C) E2-mediated
structs and E2-response plasmid, normalized to pZeoSV:βgal level=1. pLNCX-FLAG-E2
ts.
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HaCaT cells were transfected with an efﬁciency of 10–15% (as
assessed by EGFP expression from pCMV-EGFP 24 h after transfec-
tion). Before selection was initiated, approximately 5-fold higher
levels of cell death were seen in cultures transfected with full-length
and C-terminal E2 vectors compared to N-terminal E2 and empty
vector or β-galactosidase controls (Fig. 1). Similar results were found
using DAPI permeability and annexin V binding assays (data not
shown) and propidium iodide staining of unﬁxed cells (Fig. 1B).
Transient transactivation assays indicated expression of full-length E2
protein at levels sufﬁcient to transactivate and E2 responsive
promoter 2–3-fold (Fig. 1C). Due to the low transfection efﬁciency
of HaCaT cells, nuclear changes and cell death were monitored in
individual cells using EGFP-E2 fusion constructs (Fig. 1A); however,
these constructs were not used for stable transfections, since over-
expression of EGFP alone can cause apoptosis in a signiﬁcant
percentage of transfected HaCaT cells (data not shown) thus
potentially confounding any effects of E2, even though EGFP-E2
fusion proteins have been reported not to have enhanced stability
(Bellanger et al., 2001).
Following zeocin selection for stable transfectants, it was observed
that cells transduced with E2 constructs showed evidence of aFig. 2. (A) Representative phase contrast images of unﬁxed transfected cell cultures (passa
density cultures, right image shows conﬂuent culture. E2-transfected cultures (zeoE2FL and z
to empty vector (zeo) which had more typical basal epithelial cell morphology. Scale bars=
identiﬁed by bright ﬁeld microscopy. Images show the same ﬁeld under bright and phase co
control (zeo) and E2 transfectant cultures (2 FL and 3 CT clones). Graph shows mean and sdifferentiated morphology, including elongated cells, squame-like
cells and multi-layered colonies, even though the cells had been
maintained in calcium-free medium (Fig. 2A). These morphologies
were not seen in empty vector or LacZ transfectants and were similar
in appearance to HaCaT cells stimulated to differentiate by calcium
(Boukamp et al., 1988; Fig. S1). The altered morphology was more
pronounced in clonal cultures and was seen in cells with or without
continued zeocin selection, therefore the selection agent was not
responsible. Cells were examined by immunocytochemistry for
expression of markers of epidermal differentiation. Involucrin,
ﬁlaggrin and cytokeratins 1 and 10 were all expressed at high levels
in E2-transfected cells, particularly in morphologically differentiated
areas (Fig. 3). Expression of all markers was highest in areas of multi-
layered, differentiated morphology, particularly in the larger,
squame-like cells. Cells transfected with empty vector or LacZ showed
little evidence of multi-layering or differentiation, lower saturation
density and only low levels of expression of differentiationmarkers, as
is normal for HaCaT cells in the absence of exogenous differentiation
stimuli (Fig. 3). Since E2 is reported to induce senescence in HeLa cells
(Goodwin et al., 2000) and our transfected cells showed morpholog-
ical similarities with senescent cells, we looked at expression of
senescence-activated β-galactosidase (SA-βgal) (Dimri et al., 1995).
Both E2 FL and E2CT transfectants showed areas of increasedges 6 (E2 FL), 7 (E2 CT), or 9 (zeo)). Left image of each pair shows morphology of low
eoE2CT) showed higher numbers of elongated cells and stratiﬁed areas when compared
200 μm. (B) Staining for SA-β-gal. Blue-stained senescent cells (passages 8–10) were
ntrast illumination. Scale bars=100 μm. (C) Comparison of SA-β-gal positive cells in 1
tandard deviation of positive staining cells in random ﬁelds.
Fig. 3. Immunodetection of epidermal differentiation markers, ﬁlaggrin, involucrin, and cytokeratins 1 and 10 (CK1, CK10) in stably transfected and HaCaT parental cells. Images
show the same ﬁeld with ﬂuorescent and phase contrast illumination. Expression of all markers was highest in E2-transfected cells, in areas of multi-layered, differentiated
morphology, particularly in large, squame-like cells. Empty vector (zeo) transfectants showed very low levels of all markers even when cells were densely packed. For each antibody,
all images were captured at the same exposure settings. Scale bars 40 μm.
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empty vector or parental HaCaT under similar culture conditions
(Fig. 2B). SA-βgal-positive cells tended to be cells with elongatedmorphology or in differentiated areas. Overall levels of senescent cells
were similar in E2FL and E2CT transfected cells (Fig. 2C) but varied in
cultures from a few positive cells per ﬁeld to over 40%.
Fig. 4. (A) PCR detection of E2 ORF in genomic DNA of transfectants (clones and pools)
at various passage numbers (shown above each lane). M=size marker lane. E2 NT:
246 bp E2 N-terminal fragment ampliﬁed by primers speciﬁc for SV40 promoter of
pZeoSV and bp 2840–2819 of HPV-16 genome. E2 CT: 190 bp E2 C-terminal fragment,
ampliﬁed using primers E2MC and E2C, corresponding to HPV-16 bp 3529–3719. HPRT:
267 bp fragment ampliﬁed by human HPRT gene-speciﬁc primers, demonstrating the
presence of intact human DNA. (B) RT-PCR detection of E2mRNA in late passage (6–10)
transfectants. +/−=with or without reverse transcriptase in ﬁrst-strand reaction.
E2 CT: PCR for E2 C-terminal fragment, as panel A above, using 50% of ﬁrst-strand cDNA
product as template. G3PDH: PCR for 693 bp glyceraldehyde 3-phosphate dehydroge-
nase exon 2–8 fragment (positive control for cDNA synthesis) using 10% of ﬁrst-strand
cDNA template. Gel images were captured using GeneSnap (Syngene) software and
mounted with Adobe Photoshop 6.
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frequently becomes integrated into the host cell chromatin with
disruption of the E2 ORF. To check that the E2 ORFs were still intact in
stable transfectants, PCR was performed on genomic DNA. As shown
in Fig. 4, the appropriate E2 ORF fragments were obtained from
transfected cells up to at least passage 8, with no evidence of
disruption. Cells remained resistant to zeocin for at least six passages
without selection, suggesting that the zeocin resistance gene had also
remained intact. Cells at various passages were screened for
expression of E2 by western blotting, probing with anti-HPV-16 E2
SCT rabbit polyclonal antiserum (Stevenson et al., 2000). No evidence
for E2 protein expression was seen by this method. This was not
unexpected given that E2 expression in human cells at levels detectable
bywestern blotting is usually highly toxic to cells and indirect assays are
usually required. However, reverse transcriptase-PCR (RT-PCR) indi-
cated that the E2 ORF was actively transcribed (Fig. 4), although we
were unable to detect positive transactivation of an E2-responsive
promoter by transactivation assays of the stable transfectants aswe had
done in the transient phase of transfection (24–72 h). This may have
been because the transfection efﬁciency, by the reporter plasmid, of the
stable E2 transfectants was very low (≤3%) and no signiﬁcant
expression of EGFP above background could be detected.Discussion
The aim of the present study was to study the outcome of
expression of levels of HPV-16 E2 protein that permit cell growth in
the natural host cell for viral infection. This was achieved bygeneration of stably transfected keratinocyte cell lines which
expressed HPV-16 E2 using the SV40 early promoter to drive
expression. The human keratinocyte cell line HaCaT was chosen for
this study because it is immortal, non-tumorigenic, contains no
endogenous HPV sequences and is able to grow and differentiate
phenotypically as normal keratinocytes in the presence of 1.4 mM
calcium (Boukamp et al., 1988). For growth and selection, cells were
grown in low calciummedium, where the only calcium was from FCS,
which maintains HaCaT cells in an undifferentiated state.
The results showed that low levels of E2 expression were capable
of triggering keratinocytes to terminally differentiate. In the context
of the virus life cycle, this was not unexpected since, although the
virus requires the cell to remain cycling in order establish an infection
and amplify its genome, it also needs the host cell to re-enter the
differentiation process in order for the life cycle to be completed.
Hence expression of E2 may not only inﬂuence expression of E6 and
E7 and thus affect cell growth, but also stimulate differentiation. Since
HaCaT cells contain no endogenous HPV (Boukamp et al., 1988), it
cannot be that the effect of E2 was simply due to suppression of the
growth-stimulatory action of E6 and E7 as in HeLa cells (Goodwin and
DiMaio, 2000) rather it is likely that this is a direct effect by E2 on
cellular gene expression. Indeed, the HPV-8 E2 protein has been
shown to directly suppress the cellular β4-integrin promoter in
primary keratinocytes (Oldak et al., 2004). HPV-8 E2 also interacts
with C/EBP to synergistically activate the involucrin promoter in
keratinocytes (Hadaschik et al., 2003) independently of the presence
of speciﬁc E2BS or p53, while E2, C/EBP and p300 are known to co-
operate during terminal differentiation of keratinocytes (Müller et al.,
2002). The C/EBP-α and -β interaction domains were mapped to the
C-terminus of E2, consistent with our results where the C-terminal
fragment of E2 was sufﬁcient for induction of differentiation.
Overexpression of E2 in HPV-18 positive HeLa cells leads to early
apoptosis of a fraction of cells and irreversible senescence within
three days, directly linked to repression of E6 and E7 and consequent
reactivation of the p53 and pRB pathways (Desaintes et al., 1999;
Goodwin and DiMaio, 2000; Wells et al., 2003). In HPV-16-infected
cervical carcinoma cells with intact p53 and Rb pathways, Moon et al.
(2001) found no evidence of E2-induced apoptosis but ‘enlarged and
ﬂattened’ cells. In HPV-16 positive SiHa cells, expression of HPV-16 E2
induced early apoptosis (Sanchez-Perez et al., 1997). In the present
study, increased expression of SA-β-gal was seen in areas of
differentiated morphology but this may not be a direct consequence
of E2. Normal terminal differentiation of keratinocytes does not
involve senescence (Gandarillas, 2000); however, HaCaT cells cannot
completely differentiate in monolayer culture (Boukamp et al., 1988)
and may thus be expected to senesce under these conditions. This
contrasts with the widespread rapid senescence seen when E2FL was
expressed after infection of HeLa, CaSki and HT-3 cells with and
without Ad5-E2 expression vector (Goodwin et al., 2000). This effect
was attributed to loss of E7 expression (Kang et al., 2004). Since HeLa
cells are incapable of terminal differentiation, irreversible senescence
may be a default pathway for cells which exit the cell cycle. It is also
likely that the E2 expression levels using adenovirus vectors were
transient and considerably higher than in the present study.
The levels of cell death seen in E2 transfected cells 24–48 h post-
transfection, i.e. the transient phase before transgene integration,
indicated that HPV-16 E2 was also capable of inducing apoptosis in
HaCaT cells. Although it was previously shown (Webster et al., 2000)
that E2-induced apoptosis in HPV-ve cells was p53-dependent, Parish
et al. (2006) showed that HPV-16 E2 was able to induce apoptosis in
HPV-ve, p53-null Saos-2 cells in the presence of exogenously
expressed mutant p53s now able to interact with E2, but unable to
bind DNA or activate transcription. Although considered to be p53
negative, HaCaT carries two p53 mutations (H179Y and R282W) on
separate alleles (Lehman et al., 1993). In a yeast functional assay,
HaCaT p53 was found to fall into the heterozygous wild type/mutant
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different pathways for apoptosis and differentiation, with differentia-
tion requiring lower levels of p53 and possibly being transcription-
independent. Certainly HaCaT cells are capable of p53-independent
apoptosis, since irradiation in thepresence or absenceof E6andE7 led to
apoptotic cell death without any change in p53 or p21 levels (Magal et
al., 1998). However, blocking HaCaT p53 can partially block apoptosis
(Henseleit et al., 1997), suggesting that HaCaT p53 retains some activity,
but that both p53-independent and -dependent apoptosis pathways are
present. Our data indicate that induction of apoptosis and then
differentiationwas resident in the C-terminus of theHPV-16 E2 protein,
the region that interacts with p53 (Parish et al., 2006). Overexpression
of HPV-18 E2 in HeLa cells was shown to trigger apoptosis via the
extrinsic pathway by induction of caspase 8 (Desaintes et al., 1999;
Demeret et al., 2003), but thiswas a functionof nuclear expressionof the
TAD, which was lacking in our C-terminal constructs.
Therefore we propose that HPV-16 E2 has multi-functional
properties, which can inﬂuence the normal viral life cycle in
keratinocytes. When expressed at levels that allow for cell growth/
survival in a cell capable of terminal differentiation, it acts not only to
promote genome expression and replication but also to promote the
differentiation programme which is essential for the completion of
the HPV life cycle, and ultimately the assembly of viral particles.
Materials and methods
Cell culture
HaCaT cells were used throughout this study. This immortalized
cell line was derived from skin keratinocytes, contains no endogenous
HPV sequences and is capable of differentiation (Boukamp et al.,
1988). Cells were routinely maintained in a calcium-free formulation
of 1:1 Dulbecco's modiﬁed Eagle medium: Ham's F12 (DMEM:F12)
[custom-made formulation of Cat. no. 21331, Invitrogen] supplemen-
ted with 10% foetal calf serum (FCS; PAA) and split weekly when just
conﬂuent at a ratio of 1:20. HeLa cells were grown in DMEM
supplemented with 10% FCS. LNCaP cells (derived from a human
prostate carcinoma) weremaintained in RPMI containing 10% FCS and
split 1:5 when around 80% conﬂuent. For calcium-induced differen-
tiation cells were transferred to medium containing 1.4 mM (normal
DMEM:Ham's F12) or 5 mM Ca2+.
Both cell lines and stable transfectants were checked on a regular
basis for mycoplasma infection using the Stratagene mycoplasma
detection kit and found to be consistently negative. For transfection,
approximately 1.5×105 cells were plated per well in 6-well dishes and
transfected with 1 μg plasmid DNA when 70–80% conﬂuent (24–48 h)
using either Fugene6 (Roche) or ESCORT (Sigma) according to
manufacturers’ protocols. To obtain stable transfectants, cells were
passaged24–48 hafter transfection into2×10 cmdishes, selectionwith
zeocin (125 μg/ml, Invitrogen) was started 24 h later and medium
replaced twice weekly. Stably transfected cultures were maintained
either aspools or ring-cloned after 2–3 weeksof selection. Inmost cases,
zeocin selection was maintained through all subsequent passages,
although some established cultures were removed from selection and
maintained in zeocin-freemedium. Transfected cellswere split at a ratio
of 1:10 when 80–95% conﬂuent.
Plasmids
The vector pZeoSV (Invitrogen) allows constitutive expression of
cloned genes in mammalian cells under the control of the SV40
promoter, whilst expressing resistance to the antibiotic zeocin under
CMV promoter control. The ORFs encoding full-length E2 (E2FL,
aa 1–365) or E2 C-terminus (E2CT, aa 251–365) were inserted into
the SpeI site of the vector pZeoSV (Invitrogen). pZeoSVlacZ, which
encodes β-galactosidase, or the empty pZeoSV vector, was used as anegative control. Transient transfection efﬁciency was monitored
by transfection of cells with plasmid pCMV:EGFP which expresses
enhanced green ﬂuorescent protein (EGFP) under the control of the
CMV promoter (modiﬁed from pEGFP-1 (Clontech) by insertion of
the CMV promoter from pCR3 (Invitrogen)) (Schmitz, 2000).
To generate EGFP-E2 fusion constructs under the control of the CMV
promoter, the open reading frame (ORF) encoding green ﬂuorescent
protein (EGFP) was PCR-ampliﬁed from pEGFP-1 (Clontech) without
including the TAA stop codon and inserted into the retroviral expression
vector pLNCX (Clontech) to generate pLNCX-EGFP. The full-length,
wild-type HPV-16 E2 ORFwas inserted in framedownstreamof EGFP to
generate pLNCX-EGFP-E2. pCMV-EGFP-E2CT was generated by insert-
ing the truncated E2 C-terminal ORF (aa 277–365) downstream, and in-
frame with an EGFP ORF lacking a STOP codon in pCMV-EGFP.
PCR
DNA was extracted from stably transfected cell pellets by lysis in
10 mM Tris–HCl pH 8, 100 mM EDTA, 20 μg/ml RNAase A, 0.5% SDS
followed byovernight digestion at 55 °Cwith proteinase K (0.1 mg/ml),
phenol/chloroform extraction and ethanol precipitation. Interfering
agents were removed by washing in Microcon 30 (Amicon) concen-
trators. One hundred nanograms of genomic DNA was used as a
template for PCR using Immolase Taq polymerase (BioLine) and
primers speciﬁc for the E2FL and E2CT ORFs, located both within the
ORF andwithin the upstream SV40 sequence. Primer sequences were
E2C: 5′-CAGAGACTCAGTGGACAGTG-3′ (HPV-16 bp 3529–3548);
E2MC: 5′-CCAATGCCATGTAGACG-3′ (HPV-16 bp 3718–3702); E2F:
5′-GGTCACGTAGGTCTGTACTATC-3′ (HPV-16 bp 2840–2819); SV40
promoter: 5′-GCCCAGTTCCGCCCATTCTCC-3′ (SV40 promoter
(pZeoSV). The integrity of genomic DNA was checked by ampliﬁca-
tion of a 267 bp fragment of human hypoxanthine guanine phos-
phoribosyl transferase (HPRT) with the primers described in
Maitland et al. (1998). Cycling conditions were 94 °C (10 min)
followed by 35 cycles of 94 °C (1 min), 55 °C (1 min), 72 °C (2 min)
and ﬁnal extension of 72 °C (7 min). PCR products were examined by
either agarose or Visigel (Stratagene) electrophoresis.
Total RNA was prepared using RNA-bee (AMS Biotechnology),
treated with RNase-free DNase (Promega) and 1 μg reverse-tran-
scribed using oligo dT primer and Superscript II reverse transcriptase
(Invitrogen). Second-strand cDNA synthesis was performed using 10%
of the reverse transcribed product and products analyzed by agarose
or Visigel electrophoresis. Ampliﬁcation of exons 2–8 of human
glyceraldehyde-3 phosphate dehydrogenase (G3PDH) was used as a
positive control for RNA ampliﬁcation, using primers 5′-AAGGT-
GAAGGTCGGAGTCAA-3′ and 5′-GGACACGGAAGGCCATGCCA-3′.
For quantitative RT-PCR, total RNA was extracted using the
RNAeasy method (Qiagen) and 1 μg total RNA was reverse-
transcribed using random hexamer primers. Second-strand synthesis
was carried out in triplicate in an ABI 7000 thermal cycler using
30 ng of the ﬁrst-strand product, Power SYBR Green Master Mix
(Applied Biosystems) and 10 μM of each forward and reverse
primers. Ampliﬁcation of HPRT was used as an endogenous control.
Primers for involucrin (exon 1) were 5′-TCCTCCTCCAGTCAATACCC-3′
and 5′-GCTGATCCCTTTGTGTT-3′. Primers for CK10 (exons 3/4–5)
were 5′-ACGAGGAGGAAATGAAAGAC-3′ and 5′-GGACTGTAGTTC-
TATCTCCAG-3′. HPRT primers were 5'-GATGATGAACCAGGTTAT-
GACC-3' and 5'-CCAAATCCTCAGCATAATGATTAGG-3'.
Cell death
To identify potentially apoptotic cells, unﬁxed cells were stained
with 4′,6-diamidine-2-phenylindole-dihydrochloride (DAPI; Sigma)
or propidium iodide (Sigma) by adding 1 μl stain solution directly to
the medium, and examined by ﬂuorescence microscopy within
15 min (Waller et al., 2000). To label with annexinV-ALEXA568
320 J.E. Burns et al. / Virology 401 (2010) 314–321(Roche), cells were rinsed twice with PBS, and incubatedwith a 1/200
dilution of annexin in 10 mM HEPES, 140 mM NaCl, 5 mM CaCl2. Ten
to 30 min later, cells were examined on an inverted UV ﬂuorescent
microscope for staining andmorphology. In order to compare levels of
cell death, random ﬁelds were captured and the percentage of labeled
cells was counted.
To directly monitor cellular and nuclear morphology following E2
transfection, cells were transfected with EGFP-E2 fusion constructs as
described above and examined by ﬂuorescence microscopy.
Detection of senescent cells
Senescent cells were detected by staining for acidic β-galactosi-
dase according to the method of (Dimri et al., 1995). Cells were ﬁxed
with 3% formaldehyde in PBS, washed with PBS and stained overnight
at 37 °C in 40 mM citric acid/sodium phosphate buffer, pH 6.0, 5 mM
potassium ferricyanide, 5 mM potassium ferrocyanide, 150 mM
sodium chloride, 2 mM magnesium chloride, 1 mg/ml X-gal. Blue-
stained (positive) cells were identiﬁed by bright ﬁeld microscopy.
Senescent cells were quantitated by capturing 4 random ﬁelds per
culture and counting the numbers of blue and non-blue cells.
Immunohistochemistry
For immunohistochemistry, cells were grown on chamber slides,
ﬁxed with 4% paraformaldehyde in PBS and hybridized with antisera
against involucrin (Sigma), CK10 (AbCam) or ﬁlaggrin (Biogenesis)
overnight at 4 °C followed by washing and labeling with ﬂuorescently
labeled secondary antibody (anti-mouse ALEXA488 (Molecular Probes)).
For labeling with CK1 (AbCam), antigen retrieval was performed
according to manufacturer's recommendations prior to hybridization.
Cells were mounted in Vectashield and examined by ﬂuorescence
microscopy.
Transactivation assay
Transactivation assays were carried out as previously described
(Hernandez-Ramon et al., 2008). Cells were co-transfected in
triplicate in 6-well plates with 850 ng pZeoSV:E2FL, pZeoSV:E2CT or
pZeoSVlacZ and 850 ng per well of E2 response plasmid p2x2E2BS-
SV40min-EGFP. Cells were harvested 45 h after transfection and EGFP
expression was measured by FACS analysis.
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